Last reviewed · How we verify
NCT04722224
Home-based Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease
NA trial testing Home-based pulmonary rehabilitation in COPD in 50 participants. Status unknown.
30 September 2023
Quick facts
| Lead sponsor | Polytechnic Institute of Porto |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 4 January 2021 |
| Primary completion | 30 September 2023 |
| Estimated completion | 17 January 2024 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Home-based pulmonary rehabilitation
Conditions studied
- COPD — all drugs for COPD →
Sponsor
Polytechnic Institute of Porto
Who can join
Adults 40 to 90, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to assess the short-term effectiveness and responsiveness of a home-based pulmonary rehabilitation (PR) program (reabilitAR) in patients with chronic obstructive pulmonary disease (COPD). It is also an aim to establish the minimal clinically important differences for PR in patients with COPD for a novel incremental step test (exercise capacity outcome measure). Patients will be recruited at hospitals. Sociodemographic, anthropometric, and comorbidities; vital signs and peripheral oxygen saturation; symptoms (dyspnea, fatigue); lung function; functional capacity; exercise capacity; the impact of the disease, balance, and cognitive function will be collected before the reabilitAR program. Additionally, health care utilization will be registered. Then, patients will be entered into the reabilitAR program (12 weeks). The intervention consists in a strategic mixture of home visits and phone calls. The program includes exercise training and the self-management educational program Living Well with COPD. After 12 weeks all outcome measures will be reassessed. It is expected that the home-based approach will express benefits and reflect the concerns to provide appropriate responses to the patient's needs by increasing access to PR.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of a Home-Based Pulmonary Rehabilitation Program in Patients with Chronic Obstructive Pulmonary Disease in GOLD B Group: A Pilot Study.
Vilarinho R, Serra L, Coxo R, Carvalho J, et al · · 2021 · cited 2× · PMID 34064453 · DOI 10.3390/healthcare9050538
Verify or expand the search:
- PubMed search for NCT04722224
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Home-based pulmonary rehabilitation
Trials testing the same drug.
- NCT05130034 — Home-based Pulmonary Rehabilitation and Health Coaching in Fibrotic Interstitial Lung Disease · NA · completed
- NCT03561818 — Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis · NA · recruiting
- NCT03518177 — Comparison of the Effectiveness of Home and Hospital-based PR in Candidate Patients With BLVR · NA · completed
- NCT03457545 — Treating Frailty in Lung Transplant Candidates (PREHAB) · NA · completed
Other recruiting trials for COPD
Currently open trials in the same condition.
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
- NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
- NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
- NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
Other Polytechnic Institute of Porto trials
Trials by the same sponsor.
- NCT07474974 — ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive D · NA · not yet recruiting
- NCT06997861 — Medication Review Improves Pain Management and Quality of Life in Chronic Pain · NA · completed
- NCT05814978 — Effects of Scapular Therapeutic Exercise on Essential Biomechanical and Neurophysiological Parameters in Shoulder Pain C · NA · completed
- NCT05961553 — Effect of an Individual Counseling Session on Physical Activity Level of Individuals With COPD · NA · completed
- NCT05611723 — Study and Analysis of Biomechanical Parameters of Human Movement Based on Disability Indicators in Older Adults · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04722224 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Polytechnic Institute of Porto
- Last refreshed: 19 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04722224.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing